—
The global digital pathology market is likely to expand due to the rising use of advanced diagnostic tools for prompt diagnosis of chronic diseases. According to a report, titled “Digital Pathology: Global Market Analysis, Insights and Forecast, 2018-2025,” the market is likely to grow due to the increasing number of people diagnosed with related diseases. Furthermore, the global digital pathology market is likely to grow in the forthcoming years due to recent technological advancements in pathology devices. Recent advancements have induced increasing operational efficacy, which is a major factor propelling growth in the global digital pathology market.Get PDF Brochure of this Report@ https://www.fortunebusinessinsights.com/enquiry/sample/digital-pathology-market-100229
Digital pathology is applicable across diverse domains within the healthcare industry. This, as per Fortune Business Insights, is a chief driver of the global market. Digital pathology involves producing a clear predictive image using various imaging devices. Moreover, these images can be shared or transferred through digital slides. A hospital, research laboratory and any related centre can transfer the image anywhere in the world within no time. This significantly reduces the time to treat and diagnose and eliminates the need to call upon specialist for consultation. The aforementioned factors have created an increasing adoption of digital pathology over other methods.
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• 3DHistech, Inc.,
• ZIH Corp,
• Mikroscan Technologies, Inc.,
• Objective Pathology Services,
• Hamamatsu Photonics K.K.,
• F. Hoffmann-La Roche Ltd.,
• Primera Technology,
• CEREBRUM CORP,
• Nikon Corporation,
• Biogenuix,
• Indica Labs, Inc.,
• Koninklijke Philips N.V.,
• Sectra AB,
• Inspirata
Use of Digital Pathology in Surgical Procedures Has Proven Hugely Beneficial
In surgical pathology, the diagnosed tissue can be detected, diagnosed, treated, and then incised into paper thin slices. These slices are then mounted upon glass slides, which are then examined by pathologists under microscopic conditions. This method was a first of its kind and possesses very high efficiency, besides offering clear and sharp images. Furthermore, digital slides can be reproduced as many times as needed. Therefore, use of pathology in surgical procedures ensures higher surgical efficiency and reduces time required for diagnosis and operation. This has led to a rapid adoption of digital pathology around the world.
FDA Clearance for Philips’ Intellisite Pathology to Bode Well for Digital Pathology Market
In April 2017, FDA gave its approval to Philips’ Intellisite Pathology (PIPS) for manufacturing and sale in the U.S. This was the first ever digital pathology system in the market with FDA clearance. According to Fortune Business Insights, approval to Philips’ Intellisite will encourage other pathology device manufacturers to come up with their own patents and use PIPS as a reference.
Request Customization of this Report@ https://www.fortunebusinessinsights.com/enquiry/customization/digital-pathology-market-100229
Secondly, pathologists and related clinical centres that had held off buying any type of pathology systems, until they would receive clearance from a regulatory authority, would now willingly invest and buy Philips’ Intellisite due to the FDA approval. Such factors will lead to the entry of newer market players and also encourage existing companies to improvise as well as improve their product to shake off competition from Philips.
Some of the major companies that are likely to contribute to the growth of the global digital pathology market are Digipath Inc., Hamamatsu Photonics K.K., Danaher Corporation ,Koninklijke Philips N.V., Indica Labs, Inc., Nikon Corporation, Glencoe Software, Inc., PerkinElmer, Inc., Pixcelldata Ltd., and Visiopharm A/S., Leica Biosystems, 3DHISTECH, HCL Technologies, Ventana Medical Systems,Pathology Devices, Inc., OptraSCAN, Biogeniux, Sectrae and Pathcore.
By Technology:
· Whole Slide Imaging
· Image Analytics Information
· Digital Cytopathology
· Digital Holography
· Microscopy
By Geography:
· North America (USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
· Latin America (Brazil, Mexico and Rest of Latin America)
· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Browse Full Report@ https://www.fortunebusinessinsights.com/industry-reports/digital-pathology-market-100229
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Info:
Name: Mr. Ashwin Arora
Email: Send Email
Organization: Fortune Business Insights
Website: https://www.fortunebusinessinsights.com/
Release ID: 523151
Google
RSS